Syngenta Reports Higher Quarterly Earnings

USAgNet - 05/01/2026

Syngenta Group announced its financial results for the first quarter of 2026, reporting growth across all four business units with continued margin expansions. The results reflect the Group's ongoing transformation toward a igher-margin, innovation-led portfolio, with particular strength in next-generation technologies, biologicals and artificial intelligence (AI)-enabled agronomy solutions.

First quarter 2026 sales grew by 2% to $6.4 billion (-4% at CER). Syngenta Group's innovation portfolio delivered strong commercial results across all strategic geographies in the first quarter, driven by new product introductions. This good result was achieved despite a market environment shaped by geopolitical uncertainty and trade disruption.

EBITDA for the first quarter rose to $1.4 billion, up 5% (1% at CER) year-on-year. The EBITDA margin expanded by around 0.6 percentage points to 21.9%, compared to 21.4% in Q1 2025. This improvement is primarily the result of the company's focus on higher-margin business, disciplined cost management, and continued operational efficiency gains.

The Group's programs in AI continued to generate measurable business impact in Q1, with initiatives established in 2025 now scaling across the organization. Syngenta Group's deployments span product development, precision agronomy, and commercial operations, reinforcing its position as one of the leading adopters of AI technology among agricultural companies.

Syngenta Crop Protection

Syngenta Crop Protection reported Q1 sales of $3.5 billion, up 3% (-3% CER), supported by a positive business environment in China and Europe specifically.

Crop Protection sales rose by 18% (CER 5%) in Europe benefiting from favorable crop conditions and strong performance in biologicals, with approvals for ORONDIS in Austria, Germany, and the Netherlands to protect high-value crops against downy mildew.

Asia, Middle East & Africa (excluding China) grew by 3%, while China maintained its momentum with 20% year-on-year growth and a continued strong demand in biologicals. AMEA saw exceptional growth of TYMIRIUM technology and PLINAZOLIN technology, and China saw continued demand for ADEPIDYN technology and TYMIRIUM technology products.

In Brazil and LATAM sales declined 3% and 16% respectively, impacted by adverse weather in Brazil, lower pricing in Mexico, and high channel stock for key products in Argentina. TYMIRIUM technology launched in Brazil, and in Latin America, while VIRESTINA technology received its first global registration in Argentina for weed control in soybeans and cotton. INCIPIO received approval in Mexico for red mite control in hot peppers and tomatoes.

« Return to Home Page